Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by SundayMovieson May 23, 2023 3:31pm
244 Views
Post# 35460742

The market is the ultimate Judge

The market is the ultimate JudgeThe market does not lie. It just a pricing system based on the prevailling opinion at a specific time. 

Two things here to consider. 

This stock will get a bump soon based on real peer reviewed data. 
This position could be an hedge for the debt ceiling panic. 

If there is no macro shock, this stock will rise even further. 

In any case, worst case scenario this stock could be considered as an 'easy' double. 

If you think that the market will give 200$ for this stock, I think you unreasable or unknowlegeable. Perhaps, we should all call you that. Unknowlegeble. 
<< Previous
Bullboard Posts
Next >>